Transplant International · 1997 · 49 citations · 11 references
Life SciencesImmunologySurgeryImmunopharmacologyImmunoregulationTransplant ImmunologyGraft RejectionGraft-versus-host DiseaseImmunosuppressionImmunosuppressive AgentsImmunosuppressive TherapyIntestinal TransplantationGastrointestinal Graft-versus-host DiseaseImmunosuppressive Drug TherapyPost-transplant ImmunosuppressionRejection PathophysiologyT Cell-mediated Graft RejectionTreatment Of Rejection Episodes
In the present study, we examined the immunosuppressive effect of a new drug, FTY720, on small bowel transplantation (SBT) in rats. Grafts from (LEW x BN) F1-to-LEW rats treated with FTY720 at 0.5 mg/kg from day 0 to 14 post-SBT survived significantly longer than untreated grafts. In addition, the administration of FTY720 combined with cyclosporin (CyA; 5 mg/kg per day) had a synergistic effect on allograft survival. The graft-versus-host reaction (GVHR) that occurred in the LEW-to-F1 rats was markedly reduced after the administration of FTY720. FTY720 combined with a low dose of CyA completely abrogated GVHR without any adverse reaction. FTY720 treatment resulted in a significant decrease in the number of lymphocytes in the peripheral blood and the spleen, but the number of peripheral neutrophils was unchanged. Thus, FTY720 would appear to be an ideal drug to combine with CyA in order to control the immune reaction after SBT.
11
Successful small-bowel/liver transplantation
David Grant, William Wall, Richard Mimeault et al. · The Lancet · 1990 · 457 citations
Kunitomo Adachi, Toshiyuki Kohara, Noriyoshi Nakao et al. · Bioorganic & Medicinal Chemistry Letters · 1995 · 308 citations
CADAVERIC SMALL BOWEL AND SMALL BOWEL-LIVER TRANSPLANTATION IN HUMANS 1,2
Satoru Todo, Andreas G. Tzakis, Kareem Abu‐Elmagd et al. · Transplantation · 1992 · 173 citations